ALDH2 Activator Inhibits Increased Myocardial Infarction Injury by Nitroglycerin Tolerance
- 2 November 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (107), 107ra111
- https://doi.org/10.1126/scitranslmed.3002067
Abstract
Tolerance to nitroglycerin, a drug often used to treat chest pain, increases susceptibility to injury by myocardial infarction.This publication has 30 references indexed in Scilit:
- Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east AsiansNature Genetics, 2011
- Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of ApoptosisPLOS ONE, 2010
- S -Nitrosylation in Cardiovascular SignalingCirculation Research, 2010
- Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo studyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variantNature Structural & Molecular Biology, 2010
- Characterization of the East Asian Variant of Aldehyde Dehydrogenase-2Published by Elsevier BV ,2010
- IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarctionProceedings of the National Academy of Sciences of the United States of America, 2009
- Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of ɛPKC and activation of aldehyde dehydrogenase 2Journal of Molecular and Cellular Cardiology, 2009
- Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the HeartScience, 2008
- Pharmacological Inhibition of ε-Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart FailureHypertension, 2008